Financials in USD. Standardized financial statements.
A compact view of how Cynata Therapeutics Limited turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $1.89M | $2.32M | $1.65M | $7.77M | $1.55M | $7.01M | $1.31M | $1.38M | $1.75M | $1.10M |
| Revenue Growth? | -18.6% | +40.0% | -78.7% | +402.6% | -77.9% | +435.8% | -4.8% | -21.4% | +59.0% | 0.0% |
| Cost of Revenue? | $0 | $280,732 | $279,965 | $279,965 | $279,965 | $280,732 | $279,965 | $279,965 | $279,965 | $280,732 |
| Gross Profit? | $1.89M | $2.03M | $1.37M | $7.49M | $1.27M | $6.73M | $1.03M | $1.10M | $1.47M | $818,981 |
| Gross Margin? | +100.0% | +87.9% | +83.1% | +96.4% | +81.9% | +96.0% | +78.6% | +79.6% | +84.0% | +74.5% |
| Operating Expenses? | $10.01M | $11.12M | $16.26M | $12.06M | $7.35M | $10.51M | $10.06M | $6.13M | $6.33M | $6.18M |
| Operating Income? | -$8.12M | -$8.81M | -$13.00M | -$4.29M | -$5.81M | -$10.51M | -$10.06M | -$6.13M | -$6.33M | -$6.18M |
| EBITDA? | -$9.33M | -$9.95M | -$16.26M | -$13.56M | -$8.80M | -$10.23M | -$9.78M | -$5.85M | -$6.05M | -$5.90M |
| Income Before Tax | -$9.39M | -$12.06M | -$14.28M | -$5.45M | -$7.69M | -$3.64M | -$8.47M | -$4.57M | -$4.55M | -$4.94M |
| Income Tax Expense | $0 | -$2.32M | $0 | $0 | $0 | $0 | -$260,551 | -$142,925 | -$94,231 | -$147,684 |
| Net Income? | -$9.39M | -$9.74M | -$14.28M | -$5.45M | -$7.69M | -$3.64M | -$8.47M | -$4.57M | -$4.55M | -$4.94M |
| EPS? | $-0.05 | $-0.05 | $-0.10 | $-0.04 | $-0.06 | $-0.03 | $-0.08 | $-0.05 | $-0.06 | $-0.07 |
| Diluted EPS? | $-0.05 | $-0.05 | $-0.10 | $-0.04 | $-0.06 | $-0.03 | $-0.08 | $-0.05 | $-0.06 | $-0.07 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality